Related content

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men

By Laaksonen D.   Niskanen L.   Nyyssönen K.   Punnonen K.   Tuomainen T.-P.   Valkonen V.-P.   Salonen R.   Salonen J.  

Diabetologia, Vol. 47, Iss. 8, 2004-08 ,pp. : 1403-1410

Springer Publishing Company

Access to resources Recommend Favorite

Serum C-reactive protein and metabolic components

By Kawada Tomoyuki  

Endocrine, Vol. 44, Iss. 3, 2013-12 ,pp. : 819-819

Springer Publishing Company

Access to resources Recommend Favorite

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

By Sidhu J.S.   Cowan D.   Kaski J.-C.  

Journal of the American College of Cardiology, Vol. 42, Iss. 10, 2003-11 ,pp. : 1757-1763

Elsevier

Access to resources Recommend Favorite

Effect of metformin and sulfonylurea on C-reactive protein level in well-controlled type 2 diabetics with metabolic syndrome

By Akbar Daad  

Endocrine Journal, Vol. 20, Iss. 3, 2003-04 ,pp. : 215-218

Humana Press, Inc

Access to resources Recommend Favorite

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the west of Scotland coronary prevention study

By Satar N.   Gaw A.   Scherbakova O.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite